跳至主要内容
临床试验/IRCT20171009036661N2
IRCT20171009036661N2已完成3 期

The effect of intravenous calcium gluconate on abdominal pain among oral opium users suspected to lead poisoning

Kerman University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • People over 18 years old
  • Oral users of opioids with a lead level greater than 20

排除标准

  • 1. Mental retardation
  • Neuropathic diseases such as diabetes
  • Chronic pain syndromes
  • High blood pressure and heart disease
  • Contraindications for calcium gluconate injection, including sensitivity to this group of drugs. Kidney stones. Hypercalcemia. Hypophosphatemia.
  • pregnant patient
  • Patient with Asthma
  • Patients suspected of obstructive bowel obstruction or with acute abdominal symptoms
  • Other diagnosis other than lead poisoning
  • Use of psychiatric drugs
  • Chronic severe
  • History of Morphine Sensitivity

研究者

相似试验